Introduction Hypertrophic cardiomyopathy (HCM) is a genetic, hereditary disease that can manifest in asymptomatic forms or severe conditions, including sudden death, with an estimated annual incidence of 0.5–1%., Symptomatic patients with left ventricular outflow tract (LVOT) obstruction may be candidates for septal reduction therapies. Surgical treatment is considered the gold standard, especially when there is an indication for valvular intervention in the same procedure. Percutaneous treatment has shown clinical results very similar to surgery, such as symptom improvement, gradient and […]

Abstract Background No-reflow after percutaneous coronary intervention is associated with poor prognosis in patients with ST-segment elevation myocardial infarction (STEMI). SYNTAX score is a good predictor of no-reflow. Objective We aimed to evaluate whether atherosclerotic burden (Gensini score) and thrombus burden in the culprit coronary artery would improve the ability of the SYNTAX score to detect no-reflow. Methods In this prospective cohort study, consecutive patients with STEMI who presented within 12 h of onset of symptoms were selected for this […]

Abstract Fistula from left internal mammary artery (LIMA) to pulmonary artery (PA) is rarely encountered in daily practice. In recent years, endovascular therapy options have emerged for the treatment of fistula formations and replaced with surgery. A 53-year-old man admitted to our outpatient clinic with symptoms of typical angina and shortness of breath despite optimal medical therapy. In his relevant history, he had a coronary artery bypass graft (CABG) operation in 2009 in which his LIMA was anastomosed to left […]